| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | Chief Technical Officer | Common Stock | 673K | $2.14M | $3.17 | Mar 22, 2023 | Direct |
| CODEXIS, INC. | Director | Common Stock | 98.7K | $208K | $2.11 | Jun 11, 2024 | Direct |
| Allogene Therapeutics, Inc. | Chief Technical Officer | Stock Option (Right to buy) | 433K | Mar 22, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CDXS | CODEXIS, INC. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| CDXS | CODEXIS, INC. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| ALLO | Allogene Therapeutics, Inc. | Mar 22, 2023 | 2 | $0 | 4 | Mar 24, 2023 | Chief Technical Officer |
| ALLO | Allogene Therapeutics, Inc. | Mar 14, 2023 | 1 | -$46K | 4 | Mar 16, 2023 | Chief Technical Officer |
| CDXS | CODEXIS, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| ALLO | Allogene Therapeutics, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 25, 2022 | Chief Technical Officer |
| ALLO | Allogene Therapeutics, Inc. | Mar 15, 2022 | 1 | -$66.4K | 4 | Mar 17, 2022 | Chief Technical Officer |
| CDXS | CODEXIS, INC. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |